e-Drug3D

1296

METHYL AMINOLEVULINATE

DISCONTINUED


INN
METHYL AMINOLEVULINATE

cas 33320-16-0
CLASS

ANTINEOPLASTIC
PHOTODYNAMIC THERAPY
TREATMENT OF ACTINIC (SOLAR) KETATOSIS LESIONS
METABOLIC CONVERSION OF METHYL AMINOLEVULINATE (PRODRUG) TO PHOTOACTIVE PORPHYRINS (PAPS)

ROUTE (list)

TOPICAL

ATC code

L01XD03

PK parameters

Solubility

FREELY SOLUBLE IN WATER


Target

-

DrugCentral

Unknown

Download SDF file methyl 5-amino-4-oxopentanoate

Formula:
C6H11NO3

Calculated chemical properties:

MW 145.16
NB_atoms 10
XLogP -0.53
PSA 67.001
NB_HD 2
NB_HA 4
fsp3 0.67
Lipinski(0=no;1=yes) 1

FDA
NDA 021415 (label) INN (METHYL AMINOLEVULINATE HYDROCHLORIDE) METVIXIA (GALDERMA LABS LP) APPROVAL= AP YEAR= 2004 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL